IL17A and atherosclerosis: Elevated levels of IL-10 and IL-17 can inhibit the progression of atherosclerosis and significantly reduce atherosclerotic plaque, while deficiency can accelerate atherosclerotic plaque formation and atherosclerotic plaque instability [6].